Clinical Trial Update: FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFOX with cetuximab and radiotherapy for stage III esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Esophageal Cancer Stage III | Phase 2 | Status: COMPLETED